New CDMO allows Acacia Pharma to win FDA approval of nausea drug

Popular logic says you never switch horses, or CDMOs, in the middle of the stream. Biotch Acacia Pharma had to do just that to win FDA approval of Barhemsys, its treatment for postoperative nausea and vomiting. The agency seal of approval comes after it twice rebuffed the drug candidate over manufacturing concerns with Acacia’s initial production partner.